Literature DB >> 10770429

Trichoblastoma is the most common neoplasm developed in nevus sebaceus of Jadassohn: a clinicopathologic study of a series of 155 cases.

G Jaqueti1, L Requena, E Sánchez Yus.   

Abstract

Nevus sebaceus of Jadassohn is a hamartoma that combines epidermal, follicular, sebaceous, and apocrine gland abnormalities. Classically, several types of cutaneous neoplasms have been associated with this hamartoma, with basal cell carcinoma being the most frequently described malignancy. We studied a series of 155 examples of nevus sebaceus of Jadassohn with clinicopathologic correlation. Several histopathologic changes related to the age of the patients were found. In our series, we could not identify any cases of authentic basal cell carcinoma. In contrast, several examples of primitive follicular induction and of trichoblastomas were seen. Other cutaneous hamartomas, hyperplasias, and neoplasms found in our series of nevus sebaceus of Jadassohn included syringocystadenoma papilliferum, sebomatricoma, apocrine gland cyst, poroma, different histopathologic variants of warts (classic warts, tricholemmoma, and desmoplastic tricholemmoma), primitive follicular induction, and ductal induction. In our series, no examples of malignant neoplasms were identified. On the basis of these findings, the classically recommended treatment for this hamartoma, which consists of early excision to prevent the development of malignancy, seems to be inappropriate.

Entities:  

Mesh:

Year:  2000        PMID: 10770429     DOI: 10.1097/00000372-200004000-00004

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  13 in total

1.  Nevus sebaceous accompanying secondary neoplasms and unique histopathologic findings.

Authors:  Jae-Hong Kim; Hwa-Young Park; Sung Ku Ahn
Journal:  Ann Dermatol       Date:  2011-10-31       Impact factor: 1.444

2.  Evaluation and management of an unusual congenital nevus.

Authors:  K Blaire Kerwin; M Alan Menter
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-04

3.  Dermoscopic Analysis of Nevus Sebaceus of Jadassohn: A Study of 13 Cases.

Authors:  Awatef Kelati; Hanane Baybay; Salim Gallouj; Fatima Zahra Mernissi
Journal:  Skin Appendage Disord       Date:  2017-03-16

Review 4.  Common Pediatric Skin Lesions: A Comprehensive Review of the Current Literature.

Authors:  Faryan Jalalabadi; Jeffrey G Trost; Joshua A Cox; Edward I Lee; Crystal Y Pourciau
Journal:  Semin Plast Surg       Date:  2016-08       Impact factor: 2.314

Review 5.  Skin adnexal neoplasms--part 1: an approach to tumours of the pilosebaceous unit.

Authors:  K O Alsaad; N A Obaidat; D Ghazarian
Journal:  J Clin Pathol       Date:  2006-08-01       Impact factor: 3.411

6.  Multiple secondary neoplasms in nevus sebaceus excision.

Authors:  Travis S Dowdle; David A Mehegran; Dylan Maldonado; Cort D McCaughey
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-11-03

7.  Impaired hair follicle morphogenesis and cycling with abnormal epidermal differentiation in nackt mice, a cathepsin L-deficient mutation.

Authors:  Fernando Benavides; Matthew F Starost; Mónica Flores; Irma B Gimenez-Conti; Jean-Louis Guénet; Claudio J Conti
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  Development of six tumors in a sebaceus nevus of jadassohn: report of a case.

Authors:  Serap Gozel; Melahat Donmez; Noyan Can Akdur; Hulya Yikilkan
Journal:  Korean J Pathol       Date:  2013-12-24

9.  Linear nevus sebaceous syndrome in a neonate conceived by intracytoplasmic sperm injection.

Authors:  Islam Nour; Hesham Abdel-Hady; Nehad Nasef; Abdel-Azeez Shaaban
Journal:  J Clin Neonatol       Date:  2012-07

10.  Therapeutic effects of CO2 laser therapy of linear nevus sebaceous in the course of the Schimmelpenning-Feuerstein-Mims syndrome.

Authors:  Magdalena Kiedrowicz; Anna Kacalak-Rzepka; Andrzej Królicki; Romuald Maleszka; Stanisława Bielecka-Grzela
Journal:  Postepy Dermatol Alergol       Date:  2013-10-30       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.